There is a clear body of research assessing sex and gender differences in risk behaviors among people who inject drugs, however little or no research has investigated sex differences in hepatitis C (HCV) susceptibility. A newly published analysis ex…

No Clinically Relevant Drug-Drug Interactions Between Methadone or Buprenorphine/Naloxone and Anti-Viral Combination Glecaprevir and Pibrentasvir. Kosloski M, Zhao W, Asatryan A, Kort J, Geoffroy P, Liu W. Antimicrob Agents Chemother. 2017 Aug 14…

Beide Medikamente sind pangenotypisch und bieten die Option der Therapieverkürzung. Maviret® (Glecaprevir/Pibrentasvir) und Visevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) sind zugelassen zur Behandlung von Patienten mit chronsicher Hepa…

Recovery of Infectious Hepatitis C Virus from Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs Robert Heimer, Mawuena Binka, Stephen Koester, Jean-Paul C Grund, Amisha Patel, Elijah Paintsil, Brett D Li…

New findings suggest that sharing paraphernalia used to cook and prepare injection drugs does not directly lead to transmission of hepatitis C virus. According to Robert Heimer, PhD, professor of epidemiology and pharmacology at the Yale School of…

Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression. Waziry R, Hajarizadeh B, Grebely J, Amin J, Law M, Danta M, George J, Dore GJ. J Hepatol. 2017 Aug 9. pii: S0168-…